OAR 855-045-0210
Registration


(1)

A non-resident drug outlet that distributes a non-patient specific compounded drug into Oregon must be registered with the FDA as a 503B Outsourcing Facility and must register with the Board as a manufacturer drug outlet.
(2) A resident drug outlet that distributes a non-patient specific human compounded drug within or outside of Oregon must register with the FDA as a 503B Outsourcing Facility and must register with the Board as a manufacturer drug outlet.
Last Updated

Jun. 8, 2021

Rule 855-045-0210’s source at or​.us